Skip to main content

Cancer Moonshot℠ - Funding by Research Category

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download the Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2019
(Whole Dollars)
Research Category Amount1
Network for Direct Patient Engagement     $(8,795,704)
Cancer Immunotherapy Translational Science Network    

$86,782,365

Therapeutic Target Identification to Overcome Drug Resistance    

$10,028,909

A National Cancer Data Ecosystem for Sharing and Analysis    

$9,547,537

Fusion Oncoproteins in Childhood Cancers    

$38,016,479

Minimize Cancer Treatment’s Debilitating Side Effects

$6,872,822

Prevention and early detection: Implementation of Evidence-Based Approaches

$65,799,925

Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care

$-

Generation of Human Tumor Atlases

$16,440,536

Development of New Enabling Cancer Technologies

$33,547,913

Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)

$111,401

Total $258,352,183

1 Includes new obligations and recoveries from FY 2017 and FY 2018 carryover accounts.  

 

  • Posted: